Welcome to Thoughts Camera Action #ProvokingThought
A startup called Ambrosia Medical that charges $8,000 to fill your veins with the blood of young people plans to launch its first clinic in New York City at the end of this year.
Researchers who study blood transfusions called the procedure “dangerous” and said the idea behind it is based on “incorrect interpretations” of their work.
Founded by Stanford graduate Jesse Karmazin, the company recently completed the first clinical trial designed to assess the benefits of young blood transfusions.Those results have not been published.
Does young blood hold the keys to a long and healthy life? Startup founder and and Stanford Medical graduate Jesse Karmazin believes it might, so he launched a startup called Ambrosia Medical that fills older people’s veins with fresh blood from young donors.
But researchers who study the procedure say it poses major risks for patients, including an elevated risk of developing several serious conditions later in life, such as graft-versus-host disease, which can occur when transfused blood cells attack the patient’s own cells, and transfusion-associated lung injury.